Searched for
ACCRETION PHARMACEUTICALS IPO
ETMarkets Smart Talk| Building a Rs 10-lakh portfolio in 2026? Naveen Kulkarni of Axis Securities recommends 50%+ in equitiesIndian markets are at record highs. Investors are reviewing asset allocation for the coming year. Naveen Kulkarni of Axis Securities PMS su...- From overheating to caution, SME IPO valuations are normalising: Swyom Advisors’ AgarwalIndia’s SME IPO boom has delivered stellar returns in recent years, but signs of overheating are now giving way to correction and caution.
- SME IPO meltdown: 30 NSE listings in 2025 slump up to 58% versus 9 mainboard laggardsIn 2025, the Indian primary market sees 121 IPOs, but 39 stocks trade below their issue price. SME IPOs are hit hardest, with 30 in the red...
- Accretion Pharmaceuticals shares list at 22% discount over IPO price on NSE SME platformAccretion Pharmaceuticals, a Gujarat-based pharma manufacturer, concluded its SME IPO with a strong subscription of 7.31 times. The IPO, pr...
- Accretion Pharmaceuticals IPO opens for subscription: Price band, GMP among key details to knowAccretion Pharmaceuticals launched its IPO on May 14, aiming to raise Rs 29.75 crore through a fresh issue of shares, with the IPO closing ...
- Indian market pricey not expensive & FIIs will return in phases; buying into higher-ticket items: Vikas PershadVikas Pershad from M&G Investments maintains a positive outlook on the Indian market, despite high valuations and recent tariff announcemen...
- Mankind Pharma scouts for M&A deals to boost local branded bizMankind Pharma, the fourth-largest pharmaceutical company in India, led by Rajeev Juneja, is seeking mergers, acquisitions, and in-licensin...
- Buy industrials on dips; top 2 bets in two-wheeler space: Deven ChokseyDeven Choksey highlights the importance of market corrections for safe investments. He advises on potential buy opportunities in companies ...
- Over 60 IPOs came out in 2021; here’s what to buy now"Look for companies which are benefiting from the China plus strategy in the API, CRAMS segment in the chemical and pharmaceutical segments...
- Top stocks in focus on Tuesday, 9 May 2017Bharti Airtel and Future Retail will announce their financial results for the quarter ended March 31, 2017
- Planning to list Syngene, selling stake part of IPO process: Kiran Mazumdar Shaw, Biocon'Syngene is India’s leading research services company in discovery and development space, especially in the pharmaceutical sector,' says Ma...
Load More
